Quarterly Results- overall
Annual Results- Scale
Annual Results- Liquidity
Annual Results- Profitability/Return
Annual Results- Valuation
External Ecosystem
Sector
Major Subsidiaries/Associates
Key Clients
Products
Products
Product details
Operations
Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
|
Mankind Pharma Q2FY27 Results: Revenue up 17%, EBITDA margin hits 27.1%
Read More
|
|
Mankind Pharma Elevates Deepak Sharma to Senior General Manager & Head – L&D and Recruitment, India & International Business
Read More
|
|
Pink October: Mankind Pharma calls for greater awareness around breast cancer, early detection and timely treatment
Read More
|
|
Mankind Pharma promotes Aparajita Nandita Raychaudhuri to Sr. VP & Head of API Sales and Marketing
Read More
|
|
Mankind Pharma’s Q2 profit jumps 38% as revenue rises 17% to Rs 4,338 Cr
Read More
|
|
Mankind Pharma among 5 F&O stocks with a sharp rise in futures open interest
Read More
|
|
Mankind Pharma jumps 8% on Q2 earnings beat but here's why analysts remain concerned
Read More
|
|
Mankind Pharma Ltd Reports Very Positive Quarterly Financial Performance Amid Market Volatility
Read More
|
|
Mankind Pharma Ltd Sees Robust Trading Activity Amid Mid-Cap Rally
Read More
|
|
Mankind Pharma Ltd Sees Sharp Open Interest Surge Amidst Strong Price Momentum
Read More
|
|
Mankind Pharma Q2 FY27 Profit Jumps 38% to ?716 Crore as Chronic Therapies Drive Domestic Growth
Read More
|
|
Mankind Pharma Q2 PAT jumps over 37% to Rs 716 crore
Read More
|
|
Mankind Pharma Q2 Profit Jumps 39% to Rs 711 Crore on Strong Cardiac, Diabetes Drug Sales
Read More
|
|
Mankind Pharma Q2 Review: Export Momentum Continues; Systematix Maintains 'Hold'; Check Target Price
Read More
|
|
Mankind Pharma Q2 Review: Jefferies, Kotak Retain Buy After Strong Earnings. Check Target Prices
Read More
|
|
Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Technical Signals
Read More
|
|
Mankind Pharma shares jump 8%: What brokerages say after Q2 results
Read More
|
|
Mankind Pharma Shares Jump Nearly 8% After Q2 Profit Rises 39%
Read More
|
|
Mankind Pharma shares surge over 8% on strong Q2 earnings show; further growth potential ahead?
Read More
|
|
Mankind Pharma soars 11% in 2 days on strong Q2 earnings; brokerages upbeat
Read More
|
|
Mankind Pharma stock surges 9% after strong Q2 results; Kotak sees big upside, other brokerages cautious
Read More
|
|
Mankind Pharma, AIOS And EBAI Join Hands To Promote Eye Health Awareness
Read More
|
|
Mankind Pharma’s employee costs jump 15% to Rs 949 crore; field-force productivity improves
Read More
|
|
MANKIND: Chronic expansion and ACTx’s in vivo CAR-T pipeline anchor the next growth phase
Read More
|
|
MANKIND: FY26 growth priorities expand into specialty care and next-generation CAR-T
Read More
|
|
Trade Spotlight: How should you trade BSE, Mankind Pharma, Bajaj Finserv, Bharti Airtel, Zydus...
Read More
|
|
Aparajita Nandita Raychaudhuri Elevated to Senior Vice President and Head – API Sales & Marketing at Mankind Pharma
Read More
|
|
Condom selling company Mankind Pharma clocks over ?716 cr profit: Revenue increases to ?4,330 cr in Sept 20...
Read More
|
|
Earnings call transcript: Mankind Pharma posts strong Q2 2026 growth as stock rises
Read More
|
|
Earnings Central: Ather Energy turns profitable, Tata Consumer and Mankind Pharma beat Street
Read More
|
|
Mankind Pharma (MANKIND.NS) Jumps 4.49% to ?2312.0 — Bulls Now Test ?2427.6 Resistance
Read More
|
|
Mankind Pharma (NSE:MANKIND) Approves Amalgamation of Two Subsidiaries
Read More
|
|
Mankind Pharma Jumps 5% to Day High as Q2 Profit Rises 39%
Read More
|
|
Mankind Pharma Limited Reports Unaudited Standalone and Consolidated Financial Results for Q2 and H1 FY 2026-27
Read More
|
|
Mankind Pharma Ltd (NSE:MANKIND) (Q2 2027) Earnings Call Highlights: Revenue Jumps 17% as ...
Read More
|
|
Mankind Pharma Q2 FY27 Results: Revenue Up 17%, PAT Rises 38%
Read More
|
|
Mankind Pharma Q2 FY27 slides: margins expand as chronic therapies drive growth By Investing.com
Read More
|
|
Mankind Pharma Q2 PAT rises 37.7% on strong domestic chronic business
Read More
|
|
Mankind Pharma Q2 profit jumps 38 per cent to Rs 716 crore
Read More
|
|
Mankind Pharma Q2 profit jumps 39% to ?712 crore as revenue rises 17%
Read More
|
|
Mankind Pharma Q2 Profit Jumps 39% To Rs 712 Cr; Board Clears Subsidiary Mergers
Read More
|
|
Mankind Pharma Q2 results: Profit rises 39% YoY to ?711 crore as operating margins improve 300 basis points
Read More
|
|
Mankind Pharma Q2 Results: Revenue at Rs 4,433 crore, Profit beats estimates
Read More
|
|
Mankind Pharma releases audio recording of Q2FY27 earnings call
Read More
|
|
Mankind Pharma shares key business developments from Q2 & H1 of FY27
Read More
|
|
Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand
Read More
|
|
Mankind Pharma Ltd. Estimates – NSE:MANKIND
Read More
|
|
Delhi HC Settles Mankind Pharma Trademark Suit as Caremankind Hospital Agrees to Change Name
Read More
|
|
Mankind Pharma Enters CAR-T Therapy with Armed Cell Acquisition
Read More
|
|
Mankind acquires majority stake in Belgium-based Armed Cell Therapeutics
Read More
|
|
Mankind Pharma plans EUR 45 million infusion into Dutch unit and majority stake in ACTx
Read More
|
|
Mankind Pharma to Acquire 70% Stake in Armed Cell Therapeutics for Rs 511.4 Crore
Read More
|
|
Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx
Read More
|
|
Mankind Pharma to buy Belgian biotech firm for cancer-care innovation
Read More
|
|
Mankind Pharma to acquire 70% in Belgian biotech firm for €48 million
Read More
|
|
Mankind Pharma, Zydus Lifesciences among top losers, fall up to 3% after Supreme Court asks Centre to...
Read More
|
|
Stock of the day
Read More
|
|
Mankind Pharma Moves Delhi HC Against Kind Marks, Court Restrains Florakind, Coskind, 4 Others
Read More
|
|
Delhi High Court protects Mankind Pharma’s “KIND” formative marks against deceptively similar pharmaceutical marks
Read More
|